Why is Nidan Laborator. falling/rising?

As of 24-Sep, Nidan Laboratories & Healthcare Ltd is experiencing a decline in its stock price, currently at 18.70, reflecting a decrease of 0.35 or 1.84%. The stock has underperformed its sector today by 1.22%, and its delivery volume has dropped significantly, falling by 50% against the 5-day average. Over the past week, the stock has decreased by 1.84%, while its performance over the last year shows a substantial decline of 43.33%. The company's weak fundamentals are highlighted by a poor EBIT to Interest ratio of 1.75 and a low Return on Equity of 6.85%, indicating challenges in profitability and debt servicing. Additionally, the stock's return on capital employed is low at 3.4, and it has not declared results in the last six months, contributing to investor concerns.
In the broader market context, the stock's recent performance contrasts with the benchmark, as it has underperformed the Sensex, which has seen a decline of only 1.08% over the same week. While the stock has shown a slight positive return of 0.54% over the past month, its year-to-date performance is significantly worse, with a decline of 35.18% compared to the Sensex's increase of 5.97%. This consistent underperformance against the benchmark over the last three years further emphasizes the stock's struggles, as it has failed to generate positive returns in each of the last three annual periods.